what is ss-31 peptide used for SS-31 protects aging mitochondria in podocytes and PECs from - SS-31 peptidekidney improves skeletal muscle energetics and exercise Unveiling the Multifaceted Applications of SS-31 Peptide: A Deep Dive into its Therapeutic Potential

SS-31dosage Chart The SS-31 peptide, also known by its developmental codes MTP-131 and the brand name Elamipretide, has emerged as a significant molecule in the realm of therapeutic research作者：P List—MOTS-c is a mitochondrial-derived peptide thatis primarily used for fat lossbut has also shown efficacy for muscle building, improved physical performance .... This mitochondria-targeted peptide is designed to enhance cellular function, primarily by improving mitochondrial health. Its unique ability to bind to cardiolipin, a lipid exclusively found on the inner mitochondrial membrane, allows it to play a crucial role in stabilizing mitochondrial structure and function. This interaction is foundational to its diverse applications, ranging from treating specific genetic disorders to potentially combating age-related decline.

Research into SS-31 has illuminated its capacity to improve energy production and reduce oxidative stress within cells2025年10月21日—SS-31 (Elamipretide) is a mitochondria-targeted peptide designed toimprove energy production and reduce oxidative stress. Researchers have .... By restoring redox homeostasis, a critical balance between oxidation and reduction, this peptide can mitigate cellular damage. Studies have demonstrated that SS-31 treatment suppresses mitochondrial ROS production in old cardiomyocytes, suggesting a powerful role in combating age-related cellular deterioration. Furthermore, SS-31 helps your cells make energy with less waste, a fundamental mechanism that underpins its broader therapeutic effects.

Targeted Therapeutic Applications of SS-31 Peptide

The therapeutic landscape for SS-31 peptide is expansive, with ongoing research exploring its efficacy across a spectrum of conditions. One area of significant focus is its potential in neurological disorders作者：Y Zhu·2022·被引用次数：57—SS-31 was found toimprove renal microvascular remodeling, vessel tortuosity, and increased vascular densityin the MetS state by protecting mitochondria.. SS-31 is currently used as a strategy to protect against neurodegenerative diseases, offering hope for conditions characterized by neuronal loss and dysfunction. Its ability to cross the blood-brain barrier and target mitochondria within brain cells is key to this application, potentially aiding in the management of cognitive deficits associated with aging or diseases like Alzheimer's. Moreover, research indicates its utility in conditions such as stroke and traumatic brain injury, where mitigating oxidative stress and improving mitochondrial function are paramount for recovery.

Beyond neurological health, SS-31 peptide shows considerable promise in cardiovascular and renal health. Its protective effects on the heart have been noted, with studies indicating it can ameliorate issues related to improving cardiac mitochondrial dysfunction. In the context of kidney disease, SS-31 is a peptide used to target mitochondria, and it has been found to protect the kidneys from oxidative stress, inflammation, and apoptosis. Specifically, research has shown that SS-31 protects aging mitochondria in podocytes and PECs from structural degradation, thereby helping to improve renal microvascular remodeling, vessel tortuosity, and increased vascular density.Mitochondrial protein interaction landscape of SS-31 - PNAS This makes it a potential therapeutic agent for conditions like diabetic nephropathy, where the antioxidant peptide SS31 prevents oxidative stress and improves kidney functionPeptide SS-31 upregulates frataxin expression and ....

The impact of SS-31 peptide extends to skeletal muscle and exercise performance. Studies have shown that SS-31 improves skeletal muscle energetics and exercise tolerance without necessarily increasing mitochondrial content. This suggests an enhancement in the efficiency of existing mitochondria.Late-life restoration of mitochondrial function reverses ... For individuals experiencing age-related decline in muscle function or those with certain mitochondrial myopathies, SS-31 peptide could offer a novel approach to restoring vitality and physical capacity.

Furthermore, SS-31 peptide is recognized for its antioxidant/anti-inflammatory properties作者：MT Sweetwyne·2017·被引用次数：113—SS-31 protects aging mitochondria in podocytes and PECs fromstructural degradation. Age-induced glomerulosclerotic lesions are focal throughout the affected .... These broad-spectrum benefits contribute to its potential in various disease states. For instance, it has been investigated for its role in atherosclerosis, a condition driven by inflammation and oxidative stress in blood vessels.

Specific Conditions and Mechanisms of Action

A notable application of SS-31 peptide is in the treatment of Barth syndrome. Elamipretide is approved as a medication for this rare genetic disorder, which is characterized by profound mitochondrial dysfunction. By targeting and stabilizing mitochondria, SS-31 addresses a core pathological feature of this condition.

The mechanism by which SS-31 operates involves its direct interaction with the inner mitochondrial membrane. It binds to cardiolipin, a vital phospholipid that is essential for the structure and function of electron transport chain complexesExplore the potential benefits of SS-31, a peptide that targets mitochondria, inimproving exercise performance and treating various medical conditions.. This binding helps to maintain the structural integrity of the mitochondria, particularly under conditions of stress. This stabilization can lead to improved electron transport efficiency, reduced production of reactive oxygen species (ROS), and enhanced ATP synthesis.

The peptide's role as an antioxidant is a recurring theme in research. By scavenging free radicals and bolstering the cell's endogenous antioxidant defenses, SS-31 peptide acts as a shield against oxidative damage. This is particularly relevant in conditions where mitochondria damage is a key driver of pathology. The peptide supports energy, cellular repair, and anti-aging processes, underscoring its holistic impact on cellular well-being.

In summary, the SS-31 peptide is a potent therapeutic agent with a remarkable ability to target and improve mitochondrial functionTargeting Mitochondria by SS-31 Ameliorates the Whole Body ... - NIH. Its applications are diverse, spanning neurological, cardiovascular, renal, and muscular systems, as well as specific genetic disorders like Barth syndrome. As research continues to unravel the intricate mechanisms of this mitochondria-targeted peptide, its role in promoting health and combating disease is poised to expand significantly. The ongoing exploration of its benefits, alongside careful consideration of SS-31 peptide dosage and potential side effects, will be crucial in fully realizing its therapeutic potential作者：W Mitchell·2020·被引用次数：124—The mitochondria-targetedpeptide SS-31binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action..